Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target

Meinusha Govindarajan1, Salvador Mejia-Guerrero2, Shawn C Chafe3

  • 1Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada.

Cell Reports. Medicine
|January 24, 2026
PubMed

Insights

Researchers identified FAT2 as a promising cancer target using N-glycoproteomics on patient-derived xenografts. FAT2-targeted therapies, including CAR-T cells, show anti-tumor activity, especially in squamous cell cancers.

Area of Science:

  • Oncology
  • Proteomics
  • Immunotherapy

Background:

  • Cell surface proteins are crucial for cancer signaling and therapeutic targeting.
  • Profiling cell surface proteins is challenging, limiting therapeutic development.
  • Patient-derived xenografts (PDXs) offer a valuable model for cancer research.

Purpose of the Study:

  • To create a pan-cancer atlas of cancer-derived surface proteins using N-glycoproteomics.
  • To develop a pipeline for identifying immunotherapeutic targets from surface protein profiles.
  • To validate FAT2 as a potential therapeutic target for squamous cell cancers.

Main Methods:

  • N-glycoproteomics analysis of 85 patient-derived xenografts (PDXs).
  • Development of a target discovery pipeline for prioritizing surface proteins.
  • Functional studies on FAT2 in head and neck squamous cell cancer (HNSC) models.
  • Evaluation of Chimeric Antigen Receptor (CAR)-T cell therapy targeting FAT2.

Main Results:

  • Glyco PDXplorer, an in vivo atlas of cancer-derived surface proteins, was constructed.
  • FAT2 was identified as a squamous-cancer-enriched surface protein with minimal expression in normal tissues.
  • FAT2 is essential for HNSC cell growth and adhesion via surface architecture and integrin-PI3K signaling.
  • FAT2-targeted CAR-T cells demonstrated significant anti-tumor activity.

Conclusions:

  • FAT2 is a validated therapeutic target for squamous cell cancers.
  • The Glyco PDXplorer platform facilitates discovery of novel cancer targets.
  • This work establishes a foundation for FAT2-targeted therapies and broader immunotherapeutic strategies.

Related Concept Videos

Surface Tension, Capillary Action, and Viscosity02:57

Surface Tension, Capillary Action, and Viscosity

Surface Tension
The various IMFs between identical molecules of a substance are examples of cohesive forces. The molecules within a liquid are surrounded by other molecules and are attracted equally in all directions by the cohesive forces within the liquid. However, the molecules on the surface of a liquid are attracted only by about one-half as many molecules. Because of the unbalanced molecular attractions on the surface molecules, liquids contract to form a shape that minimizes the number...
33.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Fixed Action Patterns01:06

Fixed Action Patterns

A fixed action pattern (FAP) is a specific, hard-wired sequence of behaviors that occurs in response to an external stimulus, called a sign stimulus. The behavior is “fixed” because it is essentially unchangeable—proceeding similarly across individuals of a species every time it occurs.
17.6K
Action Potential01:31

Action Potential

Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
4.4K
Action Potential01:14

Action Potential

Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
10.9K